230 related articles for article (PubMed ID: 32245293)
21. Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.
Shen Y; Lu C; Tian W; Wang L; Cui B; Jiao Y; Ma C; Ju Y; Zhu L; Shao C; Liu X; Wang J; Zhang B; Lu Z
Int J Oncol; 2012 Apr; 40(4):1285-90. PubMed ID: 22200673
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
[TBL] [Abstract][Full Text] [Related]
23. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.
Sconocchia G; Lau M; Provenzano M; Rezvani K; Wongsena W; Fujiwara H; Hensel N; Melenhorst J; Li J; Ferrone S; Barrett AJ
Blood; 2005 Nov; 106(10):3666-72. PubMed ID: 16046526
[TBL] [Abstract][Full Text] [Related]
24. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos.
Nishimura Y; Maeda M; Kumagai N; Hayashi H; Miura Y; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(4):879-88. PubMed ID: 20074451
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
[TBL] [Abstract][Full Text] [Related]
26. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
27. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
Song H; Park H; Kim J; Park G; Kim YS; Kim SM; Kim D; Seo SK; Lee HK; Cho D; Hur D
Immunol Lett; 2011 May; 136(2):187-93. PubMed ID: 21277902
[TBL] [Abstract][Full Text] [Related]
28. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.
Bonacini M; Soriano A; Zerbini A; Calò E; Cimino L; Muratore F; Fontana L; Braglia L; Parmeggiani M; Salvarani C; Croci S
Front Immunol; 2018; 9():2157. PubMed ID: 30319620
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.
Park KS; Park JH; Song YW
Tissue Antigens; 2008 Oct; 72(4):342-6. PubMed ID: 18700876
[TBL] [Abstract][Full Text] [Related]
30. Permanent silencing of NKG2A expression for cell-based therapeutics.
Figueiredo C; Seltsam A; Blasczyk R
J Mol Med (Berl); 2009 Feb; 87(2):199-210. PubMed ID: 19002424
[TBL] [Abstract][Full Text] [Related]
31. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
[TBL] [Abstract][Full Text] [Related]
32. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
33. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.
Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI
Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453
[TBL] [Abstract][Full Text] [Related]
34. Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressive Effects of Mycophenolate Mofetil and Hepatitis B Virus Infection.
Dong S; Geng L; Shen MD; Zheng SS
Am J Med Sci; 2015 May; 349(5):432-7. PubMed ID: 25828197
[TBL] [Abstract][Full Text] [Related]
35. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.
Zou Y; Song ZX; Lu Y; Liang XL; Yuan Q; Liao SH; Bao JJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):509-513. PubMed ID: 27465324
[TBL] [Abstract][Full Text] [Related]
37. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
38. IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
Schilling B; Halstead ES; Schuler P; Harasymczuk M; Egan JE; Whiteside TL
Cancer Immunol Immunother; 2012 Sep; 61(9):1395-405. PubMed ID: 22270713
[TBL] [Abstract][Full Text] [Related]
39. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
40. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
